Brief: Kymera Therapeutics Q2 EPS USD -0.62
05/08/2026 12:01
BRIEF-Kymera Therapeutics Q2 EPS USD -0.62 Aug 05 (Reuters) - Kymera Therapeutics Q2 revenue USD 65 million vs. IBES estimate USD 31.2 million.
- Q2 net income USD -61.211 million
- Q2 operating expenses USD 140.607 million
Recent news on Kymera Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Adobe, Dell Technologies, Zscaler
Kymera Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Kymera Therapeutics Q2 collaboration revenue more than doubles, beats estimates
Brief: Kymera Therapeutics Q2 EPS USD -0.62
Brief: Kymera Therapeutics Appoints Terence Rooney, MD, As Chief Medical Officer